Based on the ATS and IDSA guidelines for ATM lung disease, what clinical symptomatology, microbiologic evidence, and/or radiographic findings should alert the clinician that the diagnosis of MAC lung disease should be considered?
Presenter
Professor of Medicine and Pediatrics
Medical University of South Carolina
Powers-Huggins Endowed Chair for Cystic Fibrosis
University of South Carolina
Charleston, South Carolina